What top creators are saying about Ibogaine(IBOG)

A naturally occurring psychoactive alkaloid derived from the Iboga shrub being developed for addiction and neuro-regeneration.

2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Ibogaine in the last 30 days yet.

Top creators covering Ibogaine (IBOG)

The 2 sources with the most insights about Ibogaine on Kazuha.

Latest insights about Ibogaine (IBOG)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Sunday, April 12, 2026

Bullish
Target: N/A

High-potency, high-reward biotech asset gaining bipartisan political support and institutional validation from Stanford, though currently a Schedule I substance with cardiac risks.

Wednesday, April 1, 2026

Very Bullish
Target: FDA Approval

Clinical trials show an 85-98% success rate in clearing opioid addiction and significant neuro-regenerative capacity for PTSD and TBI.

Discussed alongside Ibogaine (IBOG)

Other assets that creators frequently mention in the same content as Ibogaine.

Frequently asked

Which podcasters and creators cover Ibogaine (IBOG) the most?

The most active sources covering Ibogaine (IBOG) on Kazuha are The New York Times, Joe Rogan. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Ibogaine (IBOG) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Ibogaine (IBOG) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Ibogaine (IBOG)?

Creators covering Ibogaine (IBOG) most frequently also discuss KETM, DMT, MDMA, PSIL. See the "Discussed alongside" section above for full asset pages.